Medical News

Optimum Blood Pressure in Patients with Shock after Acute My...
J Am Coll Cardiol .

In post-cardiac arrest patients with shock after AMI, targeting MAP between 80/85 and 100 mm Hg with additional use...

14 Aug 2020

Loop Diuretic Prescription and 30-Day Outcomes in Older Pati...
J. Am. Coll. Cardiol.

Hospitalized older patients not taking diuretics prior to hospitalization for HF decompensation who received a...

13 Aug 2020

What is the Optimal Blood Pressure Level for Patients with A...
J Hypertens.

SBP values below 161 mmHg are associated higher all-cause mortality, but lower event risk in patients with atrial...

12 Aug 2020

Masked Morning Hypertension Correlated with Target Organ Dam...
J Hypertens.

The prevalence of masked morning hypertension in nondialysis chronic kidney disease patients was high, and masked...

11 Aug 2020

Key Trials

Insights from PARAGON-HF: Sacubitril/Valsartan Favorably Alter the Biomarkers of Extracellular Matrix Regulation in HFpEF Patients

This substudy of the PARAGON-HF study demonstrates the favorable impact of sacubitril/valsartan vs. valsartan alone on various biomarkers related to...

Prolonged DAPT Favorably Impacts the Risk-Benefit Ratio in ‘TWILIGHT’-like High-Risk Patients after Complex PCI

Amongst high-risk patients who underwent complex PCI, DAPT >12 months lowered the risk of ischemic events without any increase in bleeding risk...

OPTIMISE Trial: Impact of Antihypertensive Medication Reduction in Elderly Hypertensive Patients

The OPTIMSE trial demonstrates that reducing antihypertensive medication in elderly (aged 80 years and above) with SBP lower than 150 mmHg while on...

RED VELVT Study: Warfarin vs. DOAC for the Treatment of Left Ventricular Thrombi

A substantial proportion of left ventricular thrombi patients receive off-label direct oral anticoagulants (DOACs). The RED VELVT study demonstrates...

Slide Library

Medical Management Strategy of CTEPH: Role of Riociguat

Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...

 
Email this page
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

 
Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page

Our Publications

Mexiletine FAQ Booklet

Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...

Mexohar (Mexiletine) Monograph

About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...

Gutron (Midodrine hydrochloride) Monograph

Orthostatic Hypotension is common in elderly (>70 years of age) and can also occur secondary to neuropathy like in diabetes or central lesions...

Azmarda (Sacubitril/Valsartan) FAQs

This booklet on frequently asked questions on sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor (ARNI) provides...

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 

Hypertension

Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 

Poll

What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
24% (5 votes)
20-40%
19% (4 votes)
40-50%
14% (3 votes)
50-70%
14% (3 votes)
70-80%
24% (5 votes)
Almost all
5% (1 vote)
Total votes: 21